Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2LVERU® JUNIOR and 2LVERU® in the Treatment of Warts
NCT03977753Phase 4Recruiting
- Sponsor
- Labo'Life
- Start
- Feb 2020
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in warts comparing 2LVERU®/2LVERU® JUNIOR with Placebo (2 arms). Primary endpoint: Disappearance of warts at the end of treatment at 6 months. Started Feb 2020; status: recruiting.
02
Drugs
2LVERU
03
Conditions
warts
Beyond the preview
Go deeper on NCT03977753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03977753.